PHASE 1 AND 2 TRIALS OF COMBINATION THERAPY WITH GEMCITABINE AND CANDESARTAN IN ADVANCED PANCREATIC CANCER

被引：0
|
作者：
Nakai, Y. [1 ]
Isayama, H. [1 ]
Ijichi, H. [1 ]
Sasaki, T. [1 ]
Ito, Y. [2 ]
Matsubara, S. [3 ]
Yagioka, H. [4 ]
Nagano, R. [5 ]
Kawakubo, K. [1 ]
Kogure, H. [1 ]
Yamamoto, N. [1 ]
Sasahira, N. [1 ]
Hirano, K. [1 ]
Tada, M. [1 ]
Koike, K. [1 ]
机构：
[1] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo 1138654, Japan
[2] Japanese Red Cross Med Ctr, Dept Gastroenterol, Tokyo, Japan
[3] Tokyo Metropolitan Police Hosp, Dept Gastroenterol, Tokyo, Japan
[4] JR Tokyo Gen Hosp, Dept Gastroenterol, Tokyo, Japan
[5] Kanto Cent Hosp, Dept Gastroenterol, Yokohama, Kanagawa, Japan
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：123 / 123
页数：1
相关论文
共 50 条
  • [1] Phase 1 & 2 Trials of Combination Therapy with Gemcitabine/Candesartan in Advanced Pancreatic Cancer
    Nakai, Y.
    Isayama, H.
    Ijichi, H.
    Sasaki, T.
    Ito, Y.
    Matsubara, S.
    Yagioka, H.
    Kawakubo, R. Nagano K.
    Kogure, H.
    Yamamoto, N.
    Hirano, N. Sasahira K.
    Tada, M.
    Koike, K.
    PANCREAS, 2012, 41 (07) : 1147 - 1147
  • [2] Phase I trial of gemcitabine and candesartan combination therapy in normotensive patients with advanced pancreatic cancer: GECA1
    Nakai, Yousuke
    Isayama, Hiroyuki
    Ijichi, Hideaki
    Sasaki, Takashi
    Kogure, Hirofumi
    Yagioka, Hiroshi
    Miyabayashi, Koji
    Mizuno, Suguru
    Yamamoto, Keisuke
    Mouri, Dai
    Kawakubo, Kazumichi
    Yamamoto, Natsuyo
    Hirano, Kenji
    Sasahira, Naoki
    Tateishi, Keisuke
    Tada, Minoru
    Koike, Kazuhiko
    CANCER SCIENCE, 2012, 103 (08) : 1489 - 1492
  • [3] A multicenter phase II trial of gemcitabine and candesartan combination therapy in patients with advanced pancreatic cancer: GECA2
    Yousuke Nakai
    Hiroyuki Isayama
    Hideaki Ijichi
    Takashi Sasaki
    Naminatsu Takahara
    Yukiko Ito
    Saburo Matsubara
    Rie Uchino
    Hiroshi Yagioka
    Toshihiko Arizumi
    Tsuyoshi Hamada
    Koji Miyabayashi
    Suguru Mizuno
    Keisuke Yamamoto
    Hirofumi Kogure
    Natsuyo Yamamoto
    Kenji Hirano
    Naoki Sasahira
    Keisuke Tateishi
    Minoru Tada
    Kazuhiko Koike
    Investigational New Drugs, 2013, 31 : 1294 - 1299
  • [4] A multicenter phase II trial of gemcitabine and candesartan combination therapy in patients with advanced pancreatic cancer: GECA2
    Nakai, Yousuke
    Isayama, Hiroyuki
    Ijichi, Hideaki
    Sasaki, Takashi
    Takahara, Naminatsu
    Ito, Yukiko
    Matsubara, Saburo
    Uchino, Rie
    Yagioka, Hiroshi
    Arizumi, Toshihiko
    Hamada, Tsuyoshi
    Miyabayashi, Koji
    Mizuno, Suguru
    Yamamoto, Keisuke
    Kogure, Hirofumi
    Yamamoto, Natsuyo
    Hirano, Kenji
    Sasahira, Naoki
    Tateishi, Keisuke
    Tada, Minoru
    Koike, Kazuhiko
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (05) : 1294 - 1299
  • [5] Phase I study of a combination therapy of gemcitabine and candesartan in patients with advanced pancreatic cancer: GECA-1 study.
    Nakai, Y.
    Isayama, H.
    Ijichi, H.
    Sasaki, T.
    Yagioka, H.
    Kogure, H.
    Kawakubo, K.
    Yamamoto, N.
    Sasahira, N.
    Hirano, K.
    Tada, M.
    Koike, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [6] Phase I study of gemcitabine and S-1 combination therapy in patients with advanced pancreatic cancer
    Ueno, H
    Okusaka, T
    Ikeda, M
    Takezako, Y
    Morizane, C
    Furuse, J
    Ishii, H
    Nagase, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 353S - 353S
  • [7] A phase 1 trial of GSL (gemcitabine, S-1, LV) combination therapy in advanced pancreatic cancer
    Nakai, Yousuke
    Isayama, Hiroyuki
    Sasaki, Takashi
    Saito, Kei
    Takahara, Naminatsu
    Mizuno, Suguru
    Hamada, Tsuyoshi
    Miyabayashi, Koji
    Yamamoto, Keisuke
    Kogure, Hirofumi
    Yamamoto, Natsuyo
    Hirano, Kenji
    Ijichi, Hideaki
    Tateishi, Keisuke
    Tada, Minoru
    Koike, Kazuhiko
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [8] Combination therapy with Oxaliplatin plus Gemcitabine in advanced pancreatic cancer
    Klapdor, R
    Martini-Svendsen, J
    Seutter, R
    Fenner, C
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S146 - S146
  • [9] A phase I trial of gemcitabine, S-1 and LV combination (GSL) therapy in advanced pancreatic cancer
    Nakai, Yousuke
    Isayama, Hiroyuki
    Saito, Kei
    Sasaki, Takashi
    Takahara, Naminatsu
    Hamada, Tsuyoshi
    Mizuno, Suguru
    Miyabayashi, Koji
    Yamamoto, Keisuke
    Mohri, Dai
    Kogure, Hirofumi
    Yamamoto, Natsuyo
    Hirano, Kenji
    Ijichi, Hideaki
    Tateishi, Keisuke
    Tada, Minoru
    Koike, Kazuhiko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (05) : 911 - 915
  • [10] A phase II trial of gemcitabine, S-1 and LV combination therapy in patients with advanced pancreatic cancer
    Saito, K. O.
    Nakai, Y.
    Isayama, H.
    Ishigaki, K.
    Saito, T.
    Takahara, N.
    Mizuno, S.
    Kogure, H.
    Koike, K.
    ANNALS OF ONCOLOGY, 2018, 29
12345